New research combining the power of brain modeling, IBM’s AI, and the IBM Cloud sheds light on how brain cells interact in Huntington’s disease.
We’re introducing a number of significant enhancements to the IBM Q Experience quantum cloud services and software platform.
New continuous-flow approach to chemical synthesis holds promise in accelerating therapeutic discovery for drug-resistant infectious diseases and cancer.
Scientists at IBM Research-Zurich use gallium phosphide to create on-chip integrated devices using optomechanics for quantum transduction.
A comprehensive analysis of tumor ecosystems that represents an important step in research that may lead to precision medicine approaches to treat breast cancer.
IBM scientists use crowdsourcing and AI techniques to explore what different types of conversational laughter can tell us.
IBM sets new performance records for automatic captioning of broadcast news audio, with error rates of 6.5% and 5.9% on two broadcast news benchmarks.
IBM researchers introduce accumulation bit-width scaling, addressing a critical need in ultra-low-precision hardware for training deep neural networks.
A new approach to defend against adversarial attacks in non-image tasks, such as audio input and automatic speech recognition.
Meta-Experience Replay (MER) integrates meta-learning and experience replay to achieve state-of-the-art performance on continual learning benchmarks.